Meeder Asset Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,074
Closed -$4K 1893
2018
Q3
$4K Buy
1,074
+116
+12% +$432 ﹤0.01% 1388
2018
Q2
$3.6K Buy
958
+760
+384% +$2.86K ﹤0.01% 1326
2018
Q1
$1K Buy
+198
New +$1K ﹤0.01% 1526
2017
Q2
Sell
-847
Closed -$5K 2045
2017
Q1
$5K Buy
+847
New +$5K ﹤0.01% 1127